207 related articles for article (PubMed ID: 2221581)
1. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
Watanabe Y; Hashizume Y; Shimizu J; Yoshida M; Watanabe S; Iwa T; Sakai S; Migita S; Sato H; Murayama T
Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
[TBL] [Abstract][Full Text] [Related]
2. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
3. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
Nakamura H; Ishiguro K; Mori T
Cancer; 1988 Dec; 62(12):2489-97. PubMed ID: 3142676
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H
Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555
[TBL] [Abstract][Full Text] [Related]
5. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
Morikawa Y; Watanabe S; Kodama T
Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer.
Yaita H; Yasumoto K; Nagashima A; Sugimachi K; Nomoto K
J Surg Oncol; 1988 Jul; 38(3):165-72. PubMed ID: 3260643
[TBL] [Abstract][Full Text] [Related]
7. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of basic procedures for adoptive immunotherapy for gastric cancer.
Fujimoto T; Omote K; Mai M; Natsuume-Sakai S
Biotherapy; 1992; 5(2):153-63. PubMed ID: 1524956
[TBL] [Abstract][Full Text] [Related]
9. Antitumor response of regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Sugimachi K; Nomoto K
Cancer Immunol Immunother; 1998 Dec; 47(4):213-20. PubMed ID: 9875674
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
[TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients.
Hanagiri T; Takenoyama M; Yoshimatsu T; Hirashima C; Yoshino I; Nakanishi K; Nagashima A; Nomoto K; Yasumoto K
Cancer Immunol Immunother; 1996 Oct; 43(2):87-93. PubMed ID: 8954142
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-12 on the induction of cytotoxic T lymphocytes from the regional lymph node lymphocytes of patients with lung adenocarcinoma.
Hanagiri T; Yoshino I; Takenoyama M; So T; Fujie H; Imabayashi S; Eifuku R; Yoshimatsu T; Osaki T; Nakanishi R; Ichiyoshi Y; Nagashima A; Nomoto K; Yasumoto K
Jpn J Cancer Res; 1998 Feb; 89(2):192-8. PubMed ID: 9548447
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
[TBL] [Abstract][Full Text] [Related]
15. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
[TBL] [Abstract][Full Text] [Related]
16. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
[TBL] [Abstract][Full Text] [Related]
17. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model].
Hori T; Kan N; Inamoto T; Nio Y; Ohgaki K; Kodama H; Tobe T
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027
[TBL] [Abstract][Full Text] [Related]
18. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
19. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Iwata T; Uramoto H; So T; Tanaka F
Lung Cancer; 2013 Sep; 81(3):475-479. PubMed ID: 23891508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
